Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Ovarian Neoplasms drug therapy"" wg kryterium: Temat


Tytuł :
Ovarialkarzinom: Diagnostik und Therapie
Autorzy :
Buderath, P.
Kimmig, R.
Pokaż więcej
Alternatywny tytuł :
Ovarian cancer: Diagnosis and therapy
Źródło :
Der Onkologe. 26(6):569-576
Czasopismo naukowe
Tytuł :
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
Autorzy :
González-Martín, Antonio
Pothuri, Bhavana
Vergote, Ignace
DePont Christensen, René
Graybill, Whitney
Mirza, Mansoor R
McCormick, Colleen
Lorusso, Domenica
Hoskins, Paul
Freyer, Gilles
Baumann, Klaus
Jardon, Kris
Redondo, Andrés
Moore, Richard G
Vulsteke, Christof
O'Cearbhaill, Roisin E
Lund, Bente
Backes, Floor
Barretina-Ginesta, Pilar
Haggerty, Ashley F
Rubio-Pérez, Maria J
Shahin, Mark S
Mangili, Giorgia
Bradley, William H
Bruchim, Ilan
Sun, Kaiming
Malinowska, Izabela A
Li, Yong
Gupta, Divya
Monk, Bradley J
Pokaż więcej
Temat :
Administration, Oral
Adult
Aged
Aged, 80 and over
Antineoplastic Agents/therapeutic use
Combined Modality Therapy
Double-Blind Method
Female
Humans
Indazoles/adverse effects
Maintenance Chemotherapy
Middle Aged
Nausea/chemically induced
Ovarian Neoplasms/drug therapy
Piperidines/adverse effects
Poly(ADP-ribose) Polymerase Inhibitors/adverse effects
Progression-Free Survival
Quality of Life
Survival Analysis
Źródło :
González-Martín, A, Pothuri, B, Vergote, I, DePont Christensen, R, Graybill, W, Mirza, M R, McCormick, C, Lorusso, D, Hoskins, P, Freyer, G, Baumann, K, Jardon, K, Redondo, A, Moore, R G, Vulsteke, C, O'Cearbhaill, R E, Lund, B, Backes, F, Barretina-Ginesta, P, Haggerty, A F, Rubio-Pérez, M J, Shahin, M S, Mangili, G, Bradley, W H, Bruchim, I, Sun, K, Malinowska, I A, Li, Y, Gupta, D, Monk, B J & PRIMA/ENGOT-OV26/GOG-3012 Investigators 2019, ' Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer ', The New England Journal of Medicine, vol. 381, no. 25, pp. 2391-2402 . https://doi.org/10.1056/NEJMoa1910962
Opis pliku :
application/pdf
Tytuł :
Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer
Autorzy :
Coleman, Robert L
Fleming, Gini F
Brady, Mark F
Swisher, Elizabeth M
Steffensen, Karina D
Friedlander, Michael
Okamoto, Aikou
Moore, Kathleen N
Efrat Ben-Baruch, Noa
Werner, Theresa L
Cloven, Noelle G
Oaknin, Ana
DiSilvestro, Paul A
Morgan, Mark A
Nam, Joo-Hyun
Leath, Charles A
Nicum, Shibani
Hagemann, Andrea R
Littell, Ramey D
Cella, David
Baron-Hay, Sally
Garcia-Donas, Jesus
Mizuno, Mika
Bell-McGuinn, Katherine
Sullivan, Danielle M
Bach, Bruce A
Bhattacharya, Sudipta
Ratajczak, Christine K
Ansell, Peter J
Dinh, Minh H
Aghajanian, Carol
Bookman, Michael A
Pokaż więcej
Temat :
Administration, Oral
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols/adverse effects
Benzimidazoles/adverse effects
Carboplatin/administration & dosage
Combined Modality Therapy
Cystadenocarcinoma, Serous/drug therapy
Double-Blind Method
Female
Genes, BRCA1
Genes, BRCA2
Humans
Intention to Treat Analysis
Maintenance Chemotherapy
Middle Aged
Mutation
Ovarian Neoplasms/drug therapy
Paclitaxel/administration & dosage
Poly(ADP-ribose) Polymerase Inhibitors/adverse effects
Progression-Free Survival
Quality of Life
Źródło :
Coleman, R L, Fleming, G F, Brady, M F, Swisher, E M, Steffensen, K D, Friedlander, M, Okamoto, A, Moore, K N, Efrat Ben-Baruch, N, Werner, T L, Cloven, N G, Oaknin, A, DiSilvestro, P A, Morgan, M A, Nam, J-H, Leath, C A, Nicum, S, Hagemann, A R, Littell, R D, Cella, D, Baron-Hay, S, Garcia-Donas, J, Mizuno, M, Bell-McGuinn, K, Sullivan, D M, Bach, B A, Bhattacharya, S, Ratajczak, C K, Ansell, P J, Dinh, M H, Aghajanian, C & Bookman, M A 2019, ' Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer ', The New England Journal of Medicine, vol. 381, no. 25, pp. 2403-2415 . https://doi.org/10.1056/NEJMoa1909707
Tytuł :
Assessment of glutathione S-transferaseM1 (GSTM1) and its polymorphisms GSTM1 null in the response to treatment with chemotherapy in advanced ovarian carcinoma
Autorzy :
Gilberto Kendi Takeda
Daniela Batista Leite
Michele Gilvana Junqueira
Luiz Augusto Freire Lopes
Ismael Dale Cotrim Guerreiro da Silva
Fausto Farah Baracat
Pokaż więcej
Temat :
Ovarian neoplasms/drug therapy
Polymorphism
genetic
Glutathione transferase
Medicine
Źródło :
Einstein (São Paulo), Vol 9, Iss 3, Pp 367-371 (2011)
Opis pliku :
electronic resource
Relacje :
http://apps.einstein.br/revista/arquivos/PDF/1872-Einstein_v9n3_367-371_ingles.pdf; https://doaj.org/toc/1679-4508
Dostęp URL :
https://doaj.org/article/eae6cb765d7043c3bc083ace664f660b
Czasopismo naukowe
Tytuł :
Enhanced response rate to pegylated liposomal doxorubicin in high grade serous ovarian carcinomas harbouring BRCA1 and BRCA2 aberrations
Autorzy :
Gourley, Charlie
Hollis, Robert L.
Meynert, Alison M.
Churchman, Michael
Rye, Tzyvia
Mackean, Melanie
Nussey, Fiona
Arends, Mark J.
Sims, Andrew H.
Semple, Colin A.
Herrington, C. Simon
Pokaż więcej
Temat :
Retrospective Studies
Research Article
skin and connective tissue diseases
Doxorubicin/analogs & derivatives
Cystadenocarcinoma, Serous/drug therapy
BRCA2 Protein/genetics
endocrine system diseases
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Neoplasm Grading
BRCA1 Protein/genetics
Polymorphism, Single Nucleotide
Survival Rate
BRCA1
Female
BRCA2
Polyethylene Glycols/therapeutic use
Ovarian cancer
Ovarian Neoplasms/drug therapy
Aged
Middle Aged
Biomarkers, Tumor/genetics
Mutation
Follow-Up Studies
PLDH
RC254-282
Genetic Predisposition to Disease
Adult
Aged, 80 and over
Antibiotics, Antineoplastic/therapeutic use
Humans
Źródło :
Hollis, R L, Meynert, A, Churchman, M, Rye, T, Mackean, M, Nussey, F, Arends, M, Sims, A, Semple, C, Herrington, C & Gourley, C 2018, ' Enhanced response rate to pegylated liposomal doxorubicin in high grade serous ovarian carcinomas harbouring BRCA1 and BRCA2 aberrations ', BMC Cancer, vol. 18, no. 1, pp. 16 . https://doi.org/10.1186/s12885-017-3981-2
BMC Cancer, Vol 18, Iss 1, Pp 1-8 (2018)
Opis pliku :
application/pdf
Tytuł :
Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association Consortium
Autorzy :
Dixon, Suzanne C
Nagle, Christina M
Wentzensen, Nicolas
Trabert, Britton
Beeghly-Fadiel, Alicia
Schildkraut, Joellen M
Moysich, Kirsten B
deFazio, Anna
Risch, Harvey A
Rossing, Mary Anne
Doherty, Jennifer A
Wicklund, Kristine G
Goodman, Marc T
Modugno, Francesmary
Ness, Roberta B
Edwards, Robert P
Jensen, Allan
Kjær, Susanne K
Høgdall, Estrid
Berchuck, Andrew
Cramer, Daniel W
Terry, Kathryn L
Poole, Elizabeth M
Bandera, Elisa V
Paddock, Lisa E
Anton-Culver, Hoda
Ziogas, Argyrios
Menon, Usha
Gayther, Simon A
Ramus, Susan J
Gentry-Maharaj, Aleksandra
Pearce, Celeste Leigh
Wu, Anna H
Pike, Malcolm C
Webb, Penelope M
Pokaż więcej
Temat :
Analgesics/therapeutic use
Science & Technology, Life Sciences & Biomedicine, Oncology, Ovarian Cancer, Aspirin, Nonsteroidal Anti-Inflammatory Drugs, NSAID, Paracetamol, Acetaminophen, Pooled Analysis, Survival, Nonsteroidal Antiinflammatory Drugs, Aspirin, Metaanalysis, Diagnosis
Epidemiology
Anticarcinogenic Agents/therapeutic use
NSAID
aspirin
paracetamol
Female
Acetaminophen/therapeutic use
Aspirin/therapeutic use
nonsteroidal anti-inflammatory drugs
Risk Factors
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use
ovarian cancer
Ovarian Neoplasms/drug therapy
survival
Aged
Meta-Analysis
Middle Aged
acetaminophen
pooled analysis
Disease-Free Survival
Journal Article
Adult
Humans
Proportional Hazards Models
Źródło :
British Journal of Cancer, 116 (9) pp. 1223-1228. (2017)
Dixon, S C, Nagle, C M, Wentzensen, N, Trabert, B, Beeghly-Fadiel, A, Schildkraut, J M, Moysich, K B, deFazio, A, Risch, H A, Rossing, M A, Doherty, J A, Wicklund, K G, Goodman, M T, Modugno, F, Ness, R B, Edwards, R P, Jensen, A, Kjær, S K, Høgdall, E, Berchuck, A, Cramer, D W, Terry, K L, Poole, E M, Bandera, E V, Paddock, L E, Anton-Culver, H, Ziogas, A, Menon, U, Gayther, S A, Ramus, S J, Gentry-Maharaj, A, Pearce, C L, Wu, A H, Pike, M C, Webb, P M & Australian Ovarian Cancer Study Group 2017, ' Use of common analgesic medications and ovarian cancer survival : results from a pooled analysis in the Ovarian Cancer Association Consortium ', B J C, vol. 116, no. 9, pp. 1223-1228 . https://doi.org/10.1038/bjc.2017.68
British Journal of Cancer
Opis pliku :
application/pdf; text
Tytuł :
Prognostic factors for overall survival in elderly patients with advanced ovarian cancer treated with chemotherapy: Results of a pooled analysis of three GINECO phase II trials
Autorzy :
Tinquaut, F.
Freyer, G.
Chauvin, F.
Gane, N.
Pujade-Lauraine, E.
Falandry, Claire
Pokaż więcej
Temat :
Geriatric Assessment
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Female
Humans
Aged
Prospective Studies
80 and over
Prognosis
Clinical Trials
Phase II as Topic
Ovarian Neoplasms/*drug therapy/mortality
[SDV]Life Sciences [q-bio]
Źródło :
Gynecologic Oncology, Elsevier, 2016, 143 (1), pp.22-6. ⟨10.1016/j.ygyno.2016.03.018⟩
Tytuł :
Prognostic factors for overall survival in elderly patients with advanced ovarian cancer treated with chemotherapy: Results of a pooled analysis of three GINECO phase II trials
Autorzy :
Tinquaut, F.
Freyer, G.
Chauvin, F.
Gane, N.
Pujade-Lauraine, E.
Falandry, Claire
Pokaż więcej
Temat :
80 and over
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Phase II as Topic
Prospective Studies
Aged
Geriatric Assessment
Clinical Trials
[SDV]Life Sciences [q-bio]
Female
Humans
Prognosis
Ovarian Neoplasms/*drug therapy/mortality
Źródło :
Gynecologic Oncology, Elsevier, 2016, 143 (1), pp.22-6. ⟨10.1016/j.ygyno.2016.03.018⟩

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies